C4 THERAPEUTICS INC.
4.5500
27-November-24 16:45:00
15 minutes delayed
Stocks
+0.3600
+8.59%
Today's range
4.2300 - 4.6500
ISIN
N/A
Source
NASDAQ
-
C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
03 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Added to NASDAQ Biotechnology Index
17 Dec 2021 08:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results
10 Nov 2021 16:01:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
11 Aug 2021 16:02:00 By Nasdaq GlobeNewswire
-
11 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
-
21 Jun 2021 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Pricing of Public Offering
16 Jun 2021 19:51:25 By Nasdaq GlobeNewswire
-
C4 Therapeutics Launches Proposed Public Offering
14 Jun 2021 16:12:23 By Nasdaq GlobeNewswire
-
14 Jun 2021 08:00:01 By Nasdaq GlobeNewswire
-
07 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Advance CFT8919, A Selective Degrader of EGFR L858R, Into IND-enabling Studies
26 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
20 May 2021 16:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
13 May 2021 16:01:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Upcoming Investor Conferences
12 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
10 Apr 2021 15:05:00 By Nasdaq GlobeNewswire